Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.

Source:http://linkedlifedata.com/resource/pubmed/id/17000695

Clin. Cancer Res. 2006 Sep 15 12 18 5578-86

Download in:

View as

Triples

General Info

PMID
17000695